 |
인쇄하기
취소
|
Dongsung to release buccal insulin product in 2011
Dongsung Pharm plan to introduce oral insulin (Oral-lyn) for the treatment of subjects with Type-1 and Type-2 diabetes in January 2011.
In August 2008, Dongsung obtained exclusive right to market Oral-lyn in Korea from the US Generex Biotechnology Corporation, the leader in drug delivery for metabolic diseases through the inner lining of the mouth.
Generex announced on September 10 that t...
In August 2008, Dongsung obtained exclusive right to market Oral-lyn in Korea from the US Generex Biotechnology Corporation, the leader in drug delivery for metabolic diseases through the inner lining of the mouth.
Generex announced on September 10 that t...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.